Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Tamoxifen 16 Radiotherapy 9 Anastrozole 8 Letrozole 7 Chemotherapy, Adjuvant 7 Specimen Handling 6 Radiation 5 Neoadjuvant Therapy 5 Mastectomy, Segmental 5 Biopsy 5 Sentinel Lymph Node Biopsy 4 Psychiatric Rehabilitation 4 Mass Spectrometry 4 Immunohistochemistry 4 Gene Expression Profiling 4 Early Intervention, Educational 4 Counseling 4 exemestane 3 afimoxifene 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Methods 3 Mastectomy 3 Magnetic Resonance Spectroscopy 3 Fatty Acids, Omega-3 3 Chromatography, High Pressure Liquid 3 pasireotide 2 Trastuzumab 2 Standard of Care 2 Soybean Proteins 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Intraductal, Noninfiltrating × fezolinetant × Clear all

NCT06617455 2026-05-06

VEnT

University of Michigan Rogel Cancer Center

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡